| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |